Clinical Trial Update: A Single-arm Phase 2 Prospective Clinical Study of Linprixel in the Treatment of Relapsed/Refractory Autoimmune Hemolytic Anemia

View source ↗

Summary

This clinical trial update outlines a single-arm Phase 2 prospective study evaluating Linprixel for relapsed/refractory autoimmune hemolytic anemia, with status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hemolytic Anemia

Drugs mentioned

• Linprixel

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Autoimmune Hemolytic Anemia | Status: NOT_YET_RECRUITING